chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) in a 26-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 005C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-May-2021, the patient experienced PYREXIA (Fever). At the time of the report, PYREXIA (Fever) outcome was unknown.            This case was linked to MOD-2021-100556 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: Tired all day; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 30-Apr-2021 and was forwarded to Moderna on 30-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Tired all day) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination.     no medical history was provided by the reporter.     On 30-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, the patient experienced FATIGUE (Tired all day). At the time of the report, FATIGUE (Tired all day) outcome was unknown.  Action taken with mRNA-1273 in response to the event was unknown            This case was linked to MOD-2021-100394 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: itching all over the body; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching all over the body) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history reported).    On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Apr-2021, the patient experienced PRURITUS (itching all over the body). At the time of the report, PRURITUS (itching all over the body) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.    Reporter did not allow further contact
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in extremity
Clinical narrative: Pain in the arm; Headache; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 03-May-2021 and was forwarded to Moderna on 03-May-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in the arm) and HEADACHE (Headache) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039821A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Pain in the arm) and HEADACHE (Headache). At the time of the report, PAIN IN EXTREMITY (Pain in the arm) and HEADACHE (Headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication use was not reported.  Treatment information was not reported.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Chest pain, Chills, Contusion, Diarrhoea
Clinical narrative: chest pain; lymph nodes on the left side by her armpit swelled up; pain from her neck to the fingertips of her left arm; Aches everywhere; body hurt; Felt like arm was on fire; Diarrhea; Bruising; Fever; Pounding headache; Chills; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CHEST PAIN (chest pain), SWELLING (lymph nodes on the left side by her armpit swelled up), PAIN (pain from her neck to the fingertips of her left arm), PAIN (Aches everywhere) and PAIN (body hurt) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 005C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in December 2020.    On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CHEST PAIN (chest pain), SWELLING (lymph nodes on the left side by her armpit swelled up), PAIN (pain from her neck to the fingertips of her left arm), PAIN (Aches everywhere), PAIN (body hurt), BURNING SENSATION (Felt like arm was on fire), DIARRHOEA (Diarrhea), CONTUSION (Bruising), PYREXIA (Fever), HEADACHE (Pounding headache) and CHILLS (Chills). At the time of the report, CHEST PAIN (chest pain), SWELLING (lymph nodes on the left side by her armpit swelled up), PAIN (Aches everywhere), PAIN (body hurt), BURNING SENSATION (Felt like arm was on fire), CONTUSION (Bruising), PYREXIA (Fever) and CHILLS (Chills) outcome was unknown, PAIN (pain from her neck to the fingertips of her left arm) had resolved and DIARRHOEA (Diarrhea) and HEADACHE (Pounding headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication was not provided
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain, Pyrexia, Swelling
Clinical narrative: chest pain; lymph nodes on the left side by her armpit swelled up; pain from her neck to the fingertips of her left arm; Aches everywhere; body hurt; Felt like arm was on fire; Diarrhea; Bruising; Fever; Pounding headache; Chills; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CHEST PAIN (chest pain), SWELLING (lymph nodes on the left side by her armpit swelled up), PAIN (pain from her neck to the fingertips of her left arm), PAIN (Aches everywhere) and PAIN (body hurt) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 005C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in December 2020.    On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CHEST PAIN (chest pain), SWELLING (lymph nodes on the left side by her armpit swelled up), PAIN (pain from her neck to the fingertips of her left arm), PAIN (Aches everywhere), PAIN (body hurt), BURNING SENSATION (Felt like arm was on fire), DIARRHOEA (Diarrhea), CONTUSION (Bruising), PYREXIA (Fever), HEADACHE (Pounding headache) and CHILLS (Chills). At the time of the report, CHEST PAIN (chest pain), SWELLING (lymph nodes on the left side by her armpit swelled up), PAIN (Aches everywhere), PAIN (body hurt), BURNING SENSATION (Felt like arm was on fire), CONTUSION (Bruising), PYREXIA (Fever) and CHILLS (Chills) outcome was unknown, PAIN (pain from her neck to the fingertips of her left arm) had resolved and DIARRHOEA (Diarrhea) and HEADACHE (Pounding headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication was not provided
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling, Vaccination site warmth
Clinical narrative: This spontaneous case reported by a physician, describes the occurrence of vaccination site erythema (red), vaccination site swelling (swollen), vaccination site warmth (warm) and vaccination site pruritus (itchy) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 020B21A) for COVID-19 immunization. No medical history reported. On Apr 2, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On May 1, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On May 3, 2021, patient experienced vaccination site erythema (red), vaccination site swelling (swollen), vaccination site warmth (warm) and vaccination site pruritus (itchy). After the injection, patient treated with Tylenol (paracetamol) May 1, 2021, at an unspecified dose and frequency. At the time of the report, vaccination site erythema (red), vaccination site swelling (swollen), vaccination site warmth (warm) and vaccination site pruritus (itchy) outcome: unknown. The reporter did not provide any causality assessments or concomitant medications.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Dysphagia, Dyspnoea, Gait disturbance
Clinical narrative: Could barely walk; Could barely talk; Blood sugar dropped significantly; Dizzy/ Lightheaded; Unable to swallow; Weak; shortness of breath; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD GLUCOSE DECREASED (Blood sugar dropped significantly), DIZZINESS (Dizzy/ Lightheaded), DYSPHAGIA (Unable to swallow), ASTHENIA (Weak) and DYSPNOEA (shortness of breath) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038B21A and 027A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (Nasal swab test) on 12-Aug-2020. Concurrent medical conditions included Hypertension, Anxiety and Drug allergy (Allergic to Codeine - Resulted in Vomiting). Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO) and AMLODIPINE for an unknown indication.   On 26-Mar-2021 at 10:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Apr-2021, the patient experienced BLOOD GLUCOSE DECREASED (Blood sugar dropped significantly), DYSPHAGIA (Unable to swallow) and DYSPNOEA (shortness of breath). 23-Apr-2021, the patient experienced DIZZINESS (Dizzy/ Lightheaded) and ASTHENIA (Weak). On 28-Apr-2021, the patient experienced GAIT DISTURBANCE (Could barely walk) and SPEECH DISORDER (Could barely talk). At the time of the report, BLOOD GLUCOSE DECREASED (Blood sugar dropped significantly), DIZZINESS (Dizzy/ Lightheaded), DYSPHAGIA (Unable to swallow), ASTHENIA (Weak), DYSPNOEA (shortness of breath), GAIT DISTURBANCE (Could barely walk) and SPEECH DISORDER (Could barely talk) had not resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Aug-2020, Viral test: positive (Positive) Positive. On 28-Apr-2021, Blood glucose: 73 (Low) 73. On 28-Apr-2021, Blood test: normal (normal) normal.         Patient had undergone EEG, MRI scanning and was waiting for results. Treatment medicines were not inlcuded   This case was linked to MOD-2021-101864 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 02-Jul-2021: Follow Up received on 02-JUL-2021, patient demographics, concurrent medical condition, lab data, first dose information and new events updated. On 19-Jul-2021: Non significant follow up received on 19-JUL-2021.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Speech disorder, Viral test
Clinical narrative: Could barely walk; Could barely talk; Blood sugar dropped significantly; Dizzy/ Lightheaded; Unable to swallow; Weak; shortness of breath; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD GLUCOSE DECREASED (Blood sugar dropped significantly), DIZZINESS (Dizzy/ Lightheaded), DYSPHAGIA (Unable to swallow), ASTHENIA (Weak) and DYSPNOEA (shortness of breath) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038B21A and 027A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (Nasal swab test) on 12-Aug-2020. Concurrent medical conditions included Hypertension, Anxiety and Drug allergy (Allergic to Codeine - Resulted in Vomiting). Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO) and AMLODIPINE for an unknown indication.   On 26-Mar-2021 at 10:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Apr-2021, the patient experienced BLOOD GLUCOSE DECREASED (Blood sugar dropped significantly), DYSPHAGIA (Unable to swallow) and DYSPNOEA (shortness of breath). 23-Apr-2021, the patient experienced DIZZINESS (Dizzy/ Lightheaded) and ASTHENIA (Weak). On 28-Apr-2021, the patient experienced GAIT DISTURBANCE (Could barely walk) and SPEECH DISORDER (Could barely talk). At the time of the report, BLOOD GLUCOSE DECREASED (Blood sugar dropped significantly), DIZZINESS (Dizzy/ Lightheaded), DYSPHAGIA (Unable to swallow), ASTHENIA (Weak), DYSPNOEA (shortness of breath), GAIT DISTURBANCE (Could barely walk) and SPEECH DISORDER (Could barely talk) had not resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Aug-2020, Viral test: positive (Positive) Positive. On 28-Apr-2021, Blood glucose: 73 (Low) 73. On 28-Apr-2021, Blood test: normal (normal) normal.         Patient had undergone EEG, MRI scanning and was waiting for results. Treatment medicines were not inlcuded   This case was linked to MOD-2021-101864 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 02-Jul-2021: Follow Up received on 02-JUL-2021, patient demographics, concurrent medical condition, lab data, first dose information and new events updated. On 19-Jul-2021: Non significant follow up received on 19-JUL-2021.
Sex: U
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Missed her 2nd dose and its been 3months she had her 1st dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Missed her 2nd dose and its been 3months she had her 1st dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse effect.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Missed her 2nd dose and its been 3months she had her 1st dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Missed her 2nd dose and its been 3months she had her 1st dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Cyst, Headache, Lymphadenopathy, Nausea
Clinical narrative: cyst under the left and right armpit; bad headache; fever of 102.8; nauseated for several days; little sore in the muscles and bones; Lymphadenopathy; This spontaneous case was reported by a consumer and describes the occurrence of CYST (cyst under the left and right armpit), HEADACHE (bad headache), PYREXIA (fever of 102.8), NAUSEA (nauseated for several days) and ARTHRALGIA (little sore in the muscles and bones) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Apr-2021, the patient experienced LYMPHADENOPATHY (Lymphadenopathy). On an unknown date, the patient experienced CYST (cyst under the left and right armpit), HEADACHE (bad headache), PYREXIA (fever of 102.8), NAUSEA (nauseated for several days) and ARTHRALGIA (little sore in the muscles and bones). At the time of the report, CYST (cyst under the left and right armpit), HEADACHE (bad headache), PYREXIA (fever of 102.8), NAUSEA (nauseated for several days), ARTHRALGIA (little sore in the muscles and bones) and LYMPHADENOPATHY (Lymphadenopathy) outcome was unknown.            No concomitant medications were reported.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not applicable.   This case was linked to MOD-2021-102307 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: Event information is updated.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: cyst under the left and right armpit; bad headache; fever of 102.8; nauseated for several days; little sore in the muscles and bones; Lymphadenopathy; This spontaneous case was reported by a consumer and describes the occurrence of CYST (cyst under the left and right armpit), HEADACHE (bad headache), PYREXIA (fever of 102.8), NAUSEA (nauseated for several days) and ARTHRALGIA (little sore in the muscles and bones) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Apr-2021, the patient experienced LYMPHADENOPATHY (Lymphadenopathy). On an unknown date, the patient experienced CYST (cyst under the left and right armpit), HEADACHE (bad headache), PYREXIA (fever of 102.8), NAUSEA (nauseated for several days) and ARTHRALGIA (little sore in the muscles and bones). At the time of the report, CYST (cyst under the left and right armpit), HEADACHE (bad headache), PYREXIA (fever of 102.8), NAUSEA (nauseated for several days), ARTHRALGIA (little sore in the muscles and bones) and LYMPHADENOPATHY (Lymphadenopathy) outcome was unknown.            No concomitant medications were reported.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not applicable.   This case was linked to MOD-2021-102307 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: Event information is updated.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Syringe issue, Underdose
Clinical narrative: I felt some of the vaccine go on my arm and some was on the table /  I only got half the shot; apparently the syringe was defective; This spontaneous case was reported by a consumer and describes the occurrence of UNDERDOSE (I felt some of the vaccine go on my arm and some was on the table /  I only got half the shot) and SYRINGE ISSUE (apparently the syringe was defective) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003C21A and 018B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-May-2021, the patient experienced UNDERDOSE (I felt some of the vaccine go on my arm and some was on the table /  I only got half the shot) and SYRINGE ISSUE (apparently the syringe was defective). On 03-May-2021, UNDERDOSE (I felt some of the vaccine go on my arm and some was on the table /  I only got half the shot) and SYRINGE ISSUE (apparently the syringe was defective) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The Action taken with  mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable  No concomitant medications were reported No treatment medications were reported
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Medication error
Clinical narrative: Moderna vaccine leaked out on her arm; This spontaneous case was reported by a consumer and describes the occurrence of MEDICATION ERROR (Moderna vaccine leaked out on her arm) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036B21A and 037A21B) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-May-2021, the patient experienced MEDICATION ERROR (Moderna vaccine leaked out on her arm). At the time of the report, MEDICATION ERROR (Moderna vaccine leaked out on her arm) outcome was unknown. Not Provided          Concomitant medication was not provided. Treatment information was not provided.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Nausea, Pain in extremity, Vaccination site rash
Clinical narrative: Pain down from arm to forearm; Rash in left arm; Felt tired; slight headache; Slight nausea; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain down from arm to forearm), VACCINATION SITE RASH (Rash in left arm), FATIGUE (Felt tired), HEADACHE (slight headache) and NAUSEA (Slight nausea) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032B21A) for COVID-19 vaccination.     The patient's past medical history included Vestibular vertigo. Previously administered products included for an unreported indication: Cipro (No allergic reaction), Levaquin (No allergic reaction), VIT D3, CRANBERRY EXTRACT [VACCINIUM MACROCARPON] and CENTRUM SILVER [ASCORBIC ACID;CALCIUM;MINERALS NOS;RETINOL;TOCOPHERYL ACETATE;VITAMIN B NOS;VITAMINS NOS;ZINC]. Past adverse reactions to the above products included Nausea with Cipro; and Tremor with Levaquin. Concurrent medical conditions included Hypothyroidism (Not worsened) and Vestibular disorder. Concomitant products included LEVOTHYROXINE and FISH OIL for an unknown indication.    On 01-Apr-2021 at 10:10 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced PAIN IN EXTREMITY (Pain down from arm to forearm), VACCINATION SITE RASH (Rash in left arm), FATIGUE (Felt tired), HEADACHE (slight headache) and NAUSEA (Slight nausea). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Pain down from arm to forearm) was resolving and VACCINATION SITE RASH (Rash in left arm), FATIGUE (Felt tired), HEADACHE (slight headache) and NAUSEA (Slight nausea) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient reported that she had no allergies, hives, asthma or hay fever. Hypersensitivity reactions were unknown. No laboratory diagnostics test were done.  The patient did not seek medical care for the reported events. The patient did not receive any treatment for the reported events.   This case was linked to MOD-2021-103091 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 24-Jun-2021: Historical condition, historical drug, concomitant medication, new event and events outcome updated; Sender's Comments:  MOD-2021-103091:2nd dose case
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Fatigue, Nasal congestion, Nasopharyngitis, Throat irritation
Clinical narrative: throat was irritated; felt nasal congestion; Cold like symptoms; The next day I felt tired; back pain; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (back pain), THROAT IRRITATION (throat was irritated), NASAL CONGESTION (felt nasal congestion), NASOPHARYNGITIS (Cold like symptoms) and FATIGUE (The next day I felt tired) in a 26-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced BACK PAIN (back pain) and FATIGUE (The next day I felt tired). On 29-Apr-2021, the patient experienced THROAT IRRITATION (throat was irritated), NASAL CONGESTION (felt nasal congestion) and NASOPHARYNGITIS (Cold like symptoms). On 08-Apr-2021, BACK PAIN (back pain) and FATIGUE (The next day I felt tired) had resolved. On 03-May-2021, THROAT IRRITATION (throat was irritated), NASAL CONGESTION (felt nasal congestion) and NASOPHARYNGITIS (Cold like symptoms) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided. Treatment medication reported includes "Next", daily, every 6 hours for 2 days and every 8 hours the last two days to try alleviate the symptoms
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Myalgia, Nausea, Pyrexia
Clinical narrative: Lightheadedness / Dizziness; Fever; Little nausea; Muscle ache, Body ache; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Lightheadedness / Dizziness), PYREXIA (Fever), NAUSEA (Little nausea) and MYALGIA (Muscle ache, Body ache) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Apr-2021, the patient experienced DIZZINESS (Lightheadedness / Dizziness), PYREXIA (Fever), NAUSEA (Little nausea) and MYALGIA (Muscle ache, Body ache). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form. At the time of the report, DIZZINESS (Lightheadedness / Dizziness), PYREXIA (Fever), NAUSEA (Little nausea) and MYALGIA (Muscle ache, Body ache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant Medications were not provided by the reporter. Treatment includes Tylenol for 2-3 days.   This case was linked to MOD21-086334, MOD21-086333, US-MODERNATX, INC.-MOD-2021-103507 (E2B Linked Report).; Sender's Comments:  MOD21-086334:crosslinked MOD21-086333:crosslinked US-MODERNATX, INC.-MOD-2021-103507:Boyfriend's case
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Headache, Hypokinesia, Intentional product use issue, Myalgia
Clinical narrative: Delayed his second dose of vaccination; Fever 102 degree; Pain in my hands"; So week; Bad headache; Body ache; can't move very fast; This spontaneous case was reported by a consumer and describes the occurrence of INTENTIONAL PRODUCT USE ISSUE (Delayed his second dose of vaccination), PYREXIA (Fever 102 degree), PAIN IN EXTREMITY (Pain in my hands"), ASTHENIA (So week) and HEADACHE (Bad headache) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025520A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INTENTIONAL PRODUCT USE ISSUE (Delayed his second dose of vaccination), PYREXIA (Fever 102 degree), PAIN IN EXTREMITY (Pain in my hands"), ASTHENIA (So week), HEADACHE (Bad headache), MYALGIA (Body ache) and HYPOKINESIA (can't move very fast). At the time of the report, INTENTIONAL PRODUCT USE ISSUE (Delayed his second dose of vaccination), PYREXIA (Fever 102 degree), PAIN IN EXTREMITY (Pain in my hands"), ASTHENIA (So week), HEADACHE (Bad headache), MYALGIA (Body ache) and HYPOKINESIA (can't move very fast) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided. No treatment was reported   This case was linked to MOD-2021-103514 (Patient Link).
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: Delayed his second dose of vaccination; Fever 102 degree; Pain in my hands"; So week; Bad headache; Body ache; can't move very fast; This spontaneous case was reported by a consumer and describes the occurrence of INTENTIONAL PRODUCT USE ISSUE (Delayed his second dose of vaccination), PYREXIA (Fever 102 degree), PAIN IN EXTREMITY (Pain in my hands"), ASTHENIA (So week) and HEADACHE (Bad headache) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025520A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INTENTIONAL PRODUCT USE ISSUE (Delayed his second dose of vaccination), PYREXIA (Fever 102 degree), PAIN IN EXTREMITY (Pain in my hands"), ASTHENIA (So week), HEADACHE (Bad headache), MYALGIA (Body ache) and HYPOKINESIA (can't move very fast). At the time of the report, INTENTIONAL PRODUCT USE ISSUE (Delayed his second dose of vaccination), PYREXIA (Fever 102 degree), PAIN IN EXTREMITY (Pain in my hands"), ASTHENIA (So week), HEADACHE (Bad headache), MYALGIA (Body ache) and HYPOKINESIA (can't move very fast) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided. No treatment was reported   This case was linked to MOD-2021-103514 (Patient Link).
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthma, Cough, Dizziness, Fatigue
Clinical narrative: Since 2 or 3 weeks ago the asthma has intensified, her asthma medicines are no longer; tachycardia; she was cheerful , now she does not smile, is sitting, has no desire or strength to do anything; cough; can barely walk, has difficulty walking; has fatigue/tiredness; right shoulder is purple; was dizzy , felt and injured her shoulder; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (cough), GAIT DISTURBANCE (can barely walk, has difficulty walking), DIZZINESS (was dizzy , felt and injured her shoulder), ASTHMA (Since 2 or 3 weeks ago the asthma has intensified, her asthma medicines are no longer) and TACHYCARDIA (tachycardia) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039132IM) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concurrent medical conditions included Asthma. Concomitant products included GABAPENTIN and PARACETAMOL (TYLENOL) for Arthritis, MONTELUKAST and ALBUTEROL [SALBUTAMOL] for an unknown indication.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-May-2021, the patient experienced DIZZINESS (was dizzy , felt and injured her shoulder). On 04-May-2021, the patient experienced ARTHRALGIA (right shoulder is purple). On an unknown date, the patient experienced COUGH (cough), GAIT DISTURBANCE (can barely walk, has difficulty walking), ASTHMA (Since 2 or 3 weeks ago the asthma has intensified, her asthma medicines are no longer), TACHYCARDIA (tachycardia), FEELING ABNORMAL (she was cheerful , now she does not smile, is sitting, has no desire or strength to do anything) and FATIGUE (has fatigue/tiredness). At the time of the report, COUGH (cough), GAIT DISTURBANCE (can barely walk, has difficulty walking), DIZZINESS (was dizzy , felt and injured her shoulder), ASTHMA (Since 2 or 3 weeks ago the asthma has intensified, her asthma medicines are no longer), TACHYCARDIA (tachycardia), FEELING ABNORMAL (she was cheerful , now she does not smile, is sitting, has no desire or strength to do anything), ARTHRALGIA (right shoulder is purple) and FATIGUE (has fatigue/tiredness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications also include Blood pressure medication Diabetes Medication,Pills for sleeping.   Most recent FOLLOW-UP information incorporated above includes: On 04-Jun-2021: follow up on 04 JUNE-2021 new event were updated
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Gait disturbance, Tachycardia
Clinical narrative: Since 2 or 3 weeks ago the asthma has intensified, her asthma medicines are no longer; tachycardia; she was cheerful , now she does not smile, is sitting, has no desire or strength to do anything; cough; can barely walk, has difficulty walking; has fatigue/tiredness; right shoulder is purple; was dizzy , felt and injured her shoulder; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (cough), GAIT DISTURBANCE (can barely walk, has difficulty walking), DIZZINESS (was dizzy , felt and injured her shoulder), ASTHMA (Since 2 or 3 weeks ago the asthma has intensified, her asthma medicines are no longer) and TACHYCARDIA (tachycardia) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039132IM) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concurrent medical conditions included Asthma. Concomitant products included GABAPENTIN and PARACETAMOL (TYLENOL) for Arthritis, MONTELUKAST and ALBUTEROL [SALBUTAMOL] for an unknown indication.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-May-2021, the patient experienced DIZZINESS (was dizzy , felt and injured her shoulder). On 04-May-2021, the patient experienced ARTHRALGIA (right shoulder is purple). On an unknown date, the patient experienced COUGH (cough), GAIT DISTURBANCE (can barely walk, has difficulty walking), ASTHMA (Since 2 or 3 weeks ago the asthma has intensified, her asthma medicines are no longer), TACHYCARDIA (tachycardia), FEELING ABNORMAL (she was cheerful , now she does not smile, is sitting, has no desire or strength to do anything) and FATIGUE (has fatigue/tiredness). At the time of the report, COUGH (cough), GAIT DISTURBANCE (can barely walk, has difficulty walking), DIZZINESS (was dizzy , felt and injured her shoulder), ASTHMA (Since 2 or 3 weeks ago the asthma has intensified, her asthma medicines are no longer), TACHYCARDIA (tachycardia), FEELING ABNORMAL (she was cheerful , now she does not smile, is sitting, has no desire or strength to do anything), ARTHRALGIA (right shoulder is purple) and FATIGUE (has fatigue/tiredness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications also include Blood pressure medication Diabetes Medication,Pills for sleeping.   Most recent FOLLOW-UP information incorporated above includes: On 04-Jun-2021: follow up on 04 JUNE-2021 new event were updated
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Eye swelling, Hypersensitivity, Lip swelling, Peripheral swelling, Rash
Clinical narrative: allergic reaction; hives all over body; lips swollen; hands swollen, arm swollen; Arm swollen; eye swollen; Rash; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (allergic reaction), URTICARIA (hives all over body), LIP SWELLING (lips swollen), PERIPHERAL SWELLING (hands swollen, arm swollen) and PERIPHERAL SWELLING (Arm swollen) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  The patient's past medical history included No adverse reaction. Concomitant products included ROSUVASTATIN, ACETYLSALICYLIC ACID (ASPIRIN LOW) and LOSARTAN for an unknown indication.    On 29-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Apr-2021, the patient experienced HYPERSENSITIVITY (allergic reaction), URTICARIA (hives all over body), LIP SWELLING (lips swollen), PERIPHERAL SWELLING (hands swollen, arm swollen), PERIPHERAL SWELLING (Arm swollen), EYE SWELLING (eye swollen) and RASH (Rash). At the time of the report, HYPERSENSITIVITY (allergic reaction), URTICARIA (hives all over body), LIP SWELLING (lips swollen), PERIPHERAL SWELLING (hands swollen, arm swollen), PERIPHERAL SWELLING (Arm swollen), EYE SWELLING (eye swollen) and RASH (Rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication were not reported.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: allergic reaction; hives all over body; lips swollen; hands swollen, arm swollen; Arm swollen; eye swollen; Rash; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (allergic reaction), URTICARIA (hives all over body), LIP SWELLING (lips swollen), PERIPHERAL SWELLING (hands swollen, arm swollen) and PERIPHERAL SWELLING (Arm swollen) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  The patient's past medical history included No adverse reaction. Concomitant products included ROSUVASTATIN, ACETYLSALICYLIC ACID (ASPIRIN LOW) and LOSARTAN for an unknown indication.    On 29-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Apr-2021, the patient experienced HYPERSENSITIVITY (allergic reaction), URTICARIA (hives all over body), LIP SWELLING (lips swollen), PERIPHERAL SWELLING (hands swollen, arm swollen), PERIPHERAL SWELLING (Arm swollen), EYE SWELLING (eye swollen) and RASH (Rash). At the time of the report, HYPERSENSITIVITY (allergic reaction), URTICARIA (hives all over body), LIP SWELLING (lips swollen), PERIPHERAL SWELLING (hands swollen, arm swollen), PERIPHERAL SWELLING (Arm swollen), EYE SWELLING (eye swollen) and RASH (Rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication were not reported.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Pain, Pyrexia
Clinical narrative: Aches like working out too much/Body ache; Diarrhea; Intermittent fever; This spontaneous case was reported by a physician and describes the occurrence of PAIN (Aches like working out too much/Body ache), DIARRHOEA (Diarrhea) and PYREXIA (Intermittent fever) in a 36-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) injection for Hidradenitis suppurativa.    No medical history were provided by the reporter.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form and ADALIMUMAB (HUMIRA) (Subcutaneous) 1 dosage form. On an unknown date, the patient experienced PAIN (Aches like working out too much/Body ache), DIARRHOEA (Diarrhea) and PYREXIA (Intermittent fever). At the time of the report, PAIN (Aches like working out too much/Body ache), DIARRHOEA (Diarrhea) and PYREXIA (Intermittent fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided.  Treatment medications were unknown.    Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: On 06-MAY-2021, received updates to event information, reporter opinion of causality (changed from drug discontinued to Unknown), suspect drug information and narrative description. The event  "Body ache" was amended to "Aches like working out too much/Body ache ".
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: vaccine administered too early; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (vaccine administered too early) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-May-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (vaccine administered too early). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (vaccine administered too early) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Arthritis, Bone pain, Head discomfort, Hypersensitivity
Clinical narrative: twinges in my head; arthritis; bone pain,bones of shoulder and hip, sitting or laying down, hur; allergies in my head; knees hurt; This spontaneous case was reported by a consumer and describes the occurrence of HEAD DISCOMFORT (twinges in my head), ARTHRITIS (arthritis), BONE PAIN (bone pain,bones of shoulder and hip, sitting or laying down, hur), HYPERSENSITIVITY (allergies in my head) and ARTHRALGIA (knees hurt) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029H20A and 013620A) for COVID-19 vaccination.     Concomitant products included LOSARTAN and LORATADINE for an unknown indication.   On 24-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In February 2021, the patient experienced HEAD DISCOMFORT (twinges in my head), ARTHRITIS (arthritis), BONE PAIN (bone pain,bones of shoulder and hip, sitting or laying down, hur), HYPERSENSITIVITY (allergies in my head) and ARTHRALGIA (knees hurt). The patient was treated with DICLOFENAC POTASSIUM (VOLTAREN ACTI) (topical) at an unspecified dose and frequency. At the time of the report, HEAD DISCOMFORT (twinges in my head), ARTHRITIS (arthritis), BONE PAIN (bone pain,bones of shoulder and hip, sitting or laying down, hur), HYPERSENSITIVITY (allergies in my head) and ARTHRALGIA (knees hurt) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient received both scheduled doses of mRNA-1273 prior to the event, therefore action taken with the drug in the event is not applicable
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Patient received 2nd dose over 60 days after 1st dose; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received 2nd dose over 60 days after 1st dose) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044B21A and 026L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-May-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received 2nd dose over 60 days after 1st dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received 2nd dose over 60 days after 1st dose) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Constipation, Headache, Pain, Peripheral swelling
Clinical narrative: body achiness; chills; headache; swollen arm; Constipation; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 05-May-2021 and was forwarded to Moderna on 06-May-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swollen arm), CONSTIPATION (Constipation), PAIN (body achiness), CHILLS (chills) and HEADACHE (headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, the patient experienced PERIPHERAL SWELLING (swollen arm) and CHILLS (chills). 15-Apr-2021, the patient experienced CONSTIPATION (Constipation) and HEADACHE (headache). On an unknown date, the patient experienced PAIN (body achiness). On 17-Apr-2021, PERIPHERAL SWELLING (swollen arm) had resolved. At the time of the report, CONSTIPATION (Constipation), CHILLS (chills) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The Patient  daily medications include atenolol, losartan, and guaifenesin   Reporter did not allow further contact
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) in a 28-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever). At the time of the report, PYREXIA (Fever) outcome was unknown.            No concomitant medications were provided. No treatment drugs were reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-109850 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-109850: